Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 379, Issue 1-2, Pages 267-276Publisher
SPRINGER
DOI: 10.1007/s11010-013-1648-0
Keywords
Dopamine D2 receptors; Post-conditioning; Protein kinase C; Cardiomyocytes
Categories
Funding
- National Natural Science Foundation of China [81000059, 81270273, 81270311, 81070123, 81200160]
- Supporting Certificate of Heilongjiang Postdoctoral Science-Research Foundation [LBH-Q11054]
Ask authors/readers for more resources
Dopamine D2 receptors (DR2) are important regulators in many organs, including cardiac system. Protein kinase C (PKC) activation and translocation is associated with cardioprotection against ischemic post-conditioning (PC); however, the regulatory role of DR2 during this process has been unknown. This study hypothesized that the prevention of cardiomyocyte damage by DR2 activation is associated with PKC translocation to the cell membrane. In the present study, we found that the ischemia/reperfusion (I/R) increased the expressions of DR2 mRNA and protein, which were further enhanced by PC. Bromocriptine (DR2 agonist) up-regulated the PC-induced DR2 expressions, and Haloperidol (DR2 antagonist) reversed the increase of DR2 expressions by Bromocriptine. PC reduced I/R-induced cardiomyocytes damage, apoptosis and myocardial infarct size, and improved cardiac function. Compared with PC, Bromocriptine further enhanced the cardioprotective roles of PC, but Haloperidol canceled the protection effect of Bromocriptine. PC up-regulated PKC-epsilon translocation in the particulate fraction, which was further strengthened by Bromocriptine but canceled by Haloperidol. In the cytosolic fraction, the changes of the PKC-epsilon translocation were opposite to the particulate fraction. These findings suggest that DR2 activation provides cardioprotection via promoting PC-induced translocation of PKC-epsilon.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available